HealthEquity Stock Target Price and Analyst Consensus

HQY Stock  USD 69.39  2.37  3.54%   
The current analyst and expert consensus on HealthEquity is Buy, with 9 strong buy opinions. The current projected HealthEquity target price consensus is 85.18 with 11 analyst opinions. Check out Macroaxis Advice on HealthEquity to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.
The most common way HealthEquity analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview HealthEquity executives and customers to further validate their buy or sell advice. HealthEquity buy-or-sell recommendation module provides average expert sentiment on the projected HealthEquity target price to derive its highest and lowest estimates based on projected price volatility of 4.915.
Lowest Forecast
Highest Forecast
Target Price
Gross Profit is likely to rise to about 528.8 M in 2023, whereas Profit Margin is likely to drop (0.0308) in 2023. At this time, HealthEquity's Investments Current are fairly stable as compared to the past year. . Total Liabilities is likely to rise to about 1.3 B in 2023, whereas Accumulated Other Comprehensive Income is likely to drop (261.2 K) in 2023.
It's important to approach HealthEquity's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

HealthEquity Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. HealthEquity target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. HealthEquity's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions11
Lowered Outlook0
Raized Outlook0
Most HealthEquity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand HealthEquity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of HealthEquity, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

HealthEquity Target Price Projection

HealthEquity's current and average target prices are 69.39 and 85.18, respectively. The current price of HealthEquity is the price at which HealthEquity is currently trading. On the other hand, HealthEquity's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

HealthEquity Market Quote on 4th of December 2023

Low Price66.14Odds
High Price69.6Odds


Target Price

Analyst Consensus On HealthEquity Target Price

Low Estimate77.0Odds
High Estimate94.001Odds
Number of Analysts11
Standard Deviation4.915


Historical Lowest Forecast  77.0 Target Price  85.18 Highest Forecast  94.0
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on HealthEquity and the information provided on this page.

HealthEquity Analyst Ratings

HealthEquity's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about HealthEquity stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of HealthEquity's financials, market performance, and future outlook by experienced professionals. HealthEquity's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize HealthEquity price targets

HealthEquity's stock target price is an estimate of its future price, usually made by analysts. Using HealthEquity's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at HealthEquity's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if HealthEquity's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional HealthEquity Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of HealthEquity is a key component of HealthEquity valuation and have some predictive power on the future returns of a HealthEquity.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of HealthEquity's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of HealthEquity in the context of predictive analytics.
Estimates (6)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as HealthEquity. Your research has to be compared to or analyzed against HealthEquity's peers to derive any actionable benefits. When done correctly, HealthEquity's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in HealthEquity.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Impulse Idea
Invested over 100 shares
Manufacturing Idea
Invested over 40 shares
Social Domain Idea
Social Domain
Invested over 20 shares
Blockchain Idea
Invested few shares
Banking Idea
Invested over 30 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested over 70 shares
Investor Favorites Idea
Investor Favorites
Invested over 60 shares
When determining whether HealthEquity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of HealthEquity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthequity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthequity Stock:
Check out Macroaxis Advice on HealthEquity to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for HealthEquity Stock analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Find actively traded Exchange Traded Funds (ETF) from around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
The data published in HealthEquity's official financial statements usually reflect HealthEquity's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of HealthEquity. For example, before you start analyzing numbers published by HealthEquity accountants, it's critical to develop an understanding of what HealthEquity's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of HealthEquity's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, HealthEquity's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in HealthEquity's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of HealthEquity. Please utilize our Beneish M Score to check the likelihood of HealthEquity's management manipulating its earnings.